• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » 2004 Index

2004 Index

December 1, 2004
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Index to Volume 2, 2004 (issue:page)


January: Antidepressant Roundup, 2004

  • Cymbalta: Dual the Reuptake, Triple the Hype

  • ECT: The Very Latest

  • Antidepressant Updates

  • John O’Reardon on Antidepressant Augmentation


February: Battle of the Atypicals

  • Efficacy and Atypicals: It’s Hand-to-Hand Combat

  • The Diabetes Conundrum

  • Antipsychotics Update

  • John Buse on Diabetes and Atypicals


March: Treatment of Alcoholism

  • The New(er) Drugs for Alcoholism

  • All About...Antabuse!

  • Alcoholics Anonymous: A Primer

  • Stewart Gitlow on Using Benzodiazepines in Alcoholism


April: Posttraumatic Stress Disorder

  • SSRIs for PTSD: Just How Effective Are They?

  • Therapy for PTSD: What You Should Know

  • Off-Label Nostrums for PTSD

  • Edna Foa on Therapy for PTSD


May: Natural Medications in Psychiatry

  • Mood Disorders: Omega-3, SAMe, and Inositol

  • Sleep Naturally: Melatonin and Valerian

  • David Mischoulon on Natural Medications


June: Neuroimaging in Psychiatry

  • Neuroimaging: A Primer

  • Can PET Diagnose Alzheimer's?

  • Neuroanatomy: A Very Short Course

  • Darin Dougherty on Research in Neuroimaging


July: Chronic Pain and Psychiatry

  • Using Psychiatric Meds for Pain

  • Pain Treatment Update: The Opiates and NSAIDs

  • Fibromyalgia: What Should We Make of It?

  • Scott Fishman on Psychiatric Approaches to Pain


August: OCD: An Update

  • OCD: Back to Basics

  • OCD and the Brain: What we Know, Why it Matters

  • Psychotherapy for OCD

  • Lorrin Koran on Medication Treatment of OCD


September: Women’s Issues in Psychiatry

  • PMDD: What It Is, How To Help

  • SSRIs in Pregnancy: Troubling Questions Remain

  • All About... Menopause

  • Adele Viguera on Peripartum Mood Disorders


October: To Sleep, To Awake

  • Sleeping Pills: An Update

  • Provigil: It Has the Midas Touch

  • Common Sleep Disorders: What Not to Miss

  • John Winkelman on Treating Sleep Disorders


November: Suicide Prevention

  • Suicide Risk and Antidepressants: An Update

  • Predicting Suicide: Are We Any Closer?

  • Chart Documentation for Suicidal Patients

  • Shawn Shea on Assessing Suicidality


December: Sexual Dysfunction

  • PDE-5 Inhibitors: Which to Choose?

  • How to Assess Sexual Dysfunction

  • 2004 Index

  • Abraham Morgentaler on Treating Sexual Dysfunction in Men


Articles in Volume 2, 2004



  • Abilify, 2:3,6

  • Acamprosate, 3:1

  • Alcoholism, 3:1-8

  • Alcoholics Anonymous, 3:6

  • Alzheimer's disease, 6:1

  • Ambien, 10:1-2

  • Antabuse, 3:1

  • Antidepressants, 1:1

  • Antidepressant augmentation, 1:4

  • Atypical antipsychotics, 2,1-8;4:6

  • Benzodiazepines, 3:4-5;4:6;10:2

  • BuSpar augmentation, 1:5

  • Cialis, 12:1

  • Clozaril, 2:3

  • Cymbalta, 1:1;7:2

  • Depakote, 7:2;9:5

  • Diabetes and atypicals, 2:1,3-5

  • ECT, 1:1

  • Fibromyalgia, 7:3

  • Geodon, 2:3,6

  • Haldol, 2:1,2

  • Hot flashes, 1:6

  • Inositol, 5:2

  • Kava, 5:5

  • Levitra, 12:1

  • Lithium, 1:4;9:5

  • Melatonin, 5:1

  • Menopause, 9:3

  • Mirapex, 10:3,5

  • Naltrexone, 3:1

  • Neuroanatomy, 6:3;8:1

  • Neuroimaging, 6:1-8

  • Neurontin, 4:6;7:2

  • NSAIDs, 7:6

  • OCD, 6:5;8:1-8

  • Omega-3 fatty acids, 5:1,4

  • Opiates, 7:1

  • Pain and psychiatry, 7:1-8

  • Paxil for PTSD, 4:1

  • Paxil CR, 1:6;9:2

  • PET scan, 6:1

  • PMDD, 9:1

  • Pregnancy, 9:1,4-5

  • Provigil, 1:6;10:1

  • Prozac, 9:2

  • Psychotherapy for OCD, 8:3

  • Psychotherapy for PTSD, 4:1,3-5

  • PTSD, 4:1-8

  • Remeron, 1:6

  • Restoril, 10:2

  • Risperdal, 2:1-8

  • SAM-e, 5:2

  • Seroquel, 2:3,6

  • Serzone, 1:6

  • Sexual dysfunction, 12:1-8

  • Sleep disorders, 10:3-5

  • Sonata, 10:1-2

  • John's Wort, 5:5

  • Symbiax, 1:6;2:6

  • Suicidality, 11:1-8

  • Tegretol, 7:2

  • Testosterone, 1:5

  • Thyroid augmentation, 1:5

  • Topamax, 3:2;4:6

  • Trazodone, 10:2

  • Valerian, 5:3

  • Viagra, 12:1

  • Wellbutrin XL, 1:6

  • Zofran for alcoholism, 3:2

  • Zoloft, 4:1;9:2

  • Zyprexa, 2:1-8

General Psychiatry
    www.thecarlatreport.com
    Issue Date: December 1, 2004
    SUBSCRIBE NOW
    Table Of Contents
    Alfred Kinsey and the DSM
    Dr. Abraham Morgentaler on Treating Sexual Dysfunction in Men
    2004 Index
    How to Assess Sexual Dysfunction
    PDE-5 Inhibitors: Which to Choose?
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.